376 related articles for article (PubMed ID: 28710602)
1. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
2. Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1).
Higaki M; Shintani T; Hamada A; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):222-233. PubMed ID: 32185608
[TBL] [Abstract][Full Text] [Related]
3. 1α,25(OH)₂D₃ inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1.
Rosli SN; Shintani T; Toratani S; Usui E; Okamoto T
In Vitro Cell Dev Biol Anim; 2014 Oct; 50(9):802-6. PubMed ID: 24938357
[TBL] [Abstract][Full Text] [Related]
4. 1α,25OH2D3 down-regulates HBp17/FGFBP-1 expression via NF-κB pathway.
Rosli SN; Shintani T; Hayashido Y; Toratani S; Usui E; Okamoto T
J Steroid Biochem Mol Biol; 2013 Jul; 136():98-101. PubMed ID: 23104116
[TBL] [Abstract][Full Text] [Related]
5. Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D
Shintani T; Higaki M; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38713345
[TBL] [Abstract][Full Text] [Related]
6. Eldecalcitol (ED-71), an analog of 1α,25-dihydroxyvitamin D3 as a potential anti-cancer agent for oral squamous cell carcinomas.
Shintani T; Rosli SNZ; Takatsu F; Choon YF; Hayashido Y; Toratani S; Usui E; Okamoto T
J Steroid Biochem Mol Biol; 2016 Nov; 164():79-84. PubMed ID: 26444325
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis.
Begum S; Zhang Y; Shintani T; Toratani S; Sato JD; Okamoto T
Oncol Rep; 2007 Mar; 17(3):591-6. PubMed ID: 17273738
[TBL] [Abstract][Full Text] [Related]
8. Heparin-Binding Protein 17/Fibroblast Growth Factor-Binding Protein-1 Knockout Inhibits Proliferation and Induces Differentiation of Squamous Cell Carcinoma Cells.
Shintani T; Higaki M; Okamoto T
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072393
[TBL] [Abstract][Full Text] [Related]
9. Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways.
Oak ASW; Bocheva G; Kim TK; Brożyna AA; Janjetovic Z; Athar M; Tuckey RC; Slominski AT
Anticancer Res; 2020 May; 40(5):2467-2474. PubMed ID: 32366390
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion.
Myoung H; Hong SP; Yun PY; Lee JH; Kim MJ
Cancer Sci; 2003 Feb; 94(2):215-20. PubMed ID: 12708500
[TBL] [Abstract][Full Text] [Related]
11. 1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
Sundaram K; Sambandam Y; Tsuruga E; Wagner CL; Reddy SV
Horm Cancer; 2014 Apr; 5(2):90-7. PubMed ID: 24497297
[TBL] [Abstract][Full Text] [Related]
12. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
[TBL] [Abstract][Full Text] [Related]
14. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Harada K; Supriatno ; Kawashima Y; Yoshida H; Sato M
Int J Oncol; 2007 Feb; 30(2):365-74. PubMed ID: 17203218
[TBL] [Abstract][Full Text] [Related]
15. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
16. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
[TBL] [Abstract][Full Text] [Related]
17. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
Fernandez-Garcia NI; Palmer HG; Garcia M; Gonzalez-Martin A; del Rio M; Barettino D; Volpert O; Muñoz A; Jimenez B
Oncogene; 2005 Sep; 24(43):6533-44. PubMed ID: 16007183
[TBL] [Abstract][Full Text] [Related]
18. CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas.
Slominski AT; Brożyna AA; Kim TK; Elsayed MM; Janjetovic Z; Qayyum S; Slominski RM; Oak ASW; Li C; Podgorska E; Li W; Jetten AM; Tuckey RC; Tang EKY; Elmets C; Athar M
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35775377
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
20. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]